×

Subscribe Today

Get our free articles delivered directly to your email!

Continue reading

Contact Us
About Us
Subscribe
My Portfolio
My Account
Contact Us
About Us
Subscribe
My Account
My Portfolio

23andMe Holding Co. (ME) NASDAQ

$0.51 0.15 (41.91%)

Market Cap: $112.36M

As of 04/18/24 04:00 PM EDT. Market closed.

(ME)

23andMe Holding Co. (ME)
NASDAQ

$0.51
0.15 (41.91%)

Market Cap: $112.36M

As of 04/18/24 04:00 PM EDT. Market closed.

Add to Portfolio

23andme is the leading personal genetics company dedicated to helping individuals understand their own genetic information through dna analysis technologies and web-based interactive tools. the company's personal genome service® enables individuals to gain deeper insights into their ancestry and genetic make-up. the vision for 23andme is to personalize healthcare by making and supporting ... read more

23andme is the leading personal genetics company dedicated to helping individuals understand their own genetic information through dna analysis technologies and web-based interactive tools. the company's personal genome service® enables individuals to gain deeper insights into their ancestry and genetic make-up. the vision for 23andme is to personalize healthcare by making and supporting meaningful discoveries through genetic research. 23andme was founded in 2006, and the company is advised by a group of renowned experts in the fields of human genetics, bioinformatics and computer science. read less

COMPANY PROFILE
Sector
Manufacturing
Industry
Pharmaceutical Preparation Manufacturing
URL
23andme.com
Address
.
Sector
Manufacturing
Industry
Pharmaceutical Preparation Manufacturing
Full Time Employees
857
URL
23andme.com
Address
.
PRICE CHART FOR 23ANDME HOLDING CO
1w
1m
3m
6m
YTD
1y
5y
MAX
From: To:
NEWS
LOADING...
INSIDEARBITRAGE ARTICLES
LOADING...
KEY STATS
Open
$0.47
Previous Close
$0.36
Days Range
$0.43 - $0.62
52 week range
$0.35 - $2.21
Volume
59,608,675
Avg. Volume (30 days)
4,435,309
Market Cap
$112.36M
Dividend Yield
-
P/E
(0.22)
Shares Outstanding
315,436,358
Open
$0.47
Previous Close
$0.36
Days Range
$0.43 - $0.62
52 week range
$0.35 - $2.21
Volume
59,608,675
Avg. Volume (30 days)
4,435,309
Market Cap
$112.36M
Dividend Yield
-
P/E
(0.22)
Shares Outstanding
315,436,358
FINANCIAL STATEMENTS FOR 23ANDME HOLDING CO
LOADING...

Open in: SeekingAlpha Yahoo Finance Fidelity MorningStar

Open in: SeekingAlpha Yahoo Finance Fidelity MorningStar

INSIDER TRANSACTIONS FOR 23ANDME HOLDING CO
OwnerRelationshipDateTransactionCost# SharesValue($)Total SharesForm 4
HIBBS KATHY LChief Administrative OfficerApr 04, 2024 Option Exercise$0.4238,54816,1901,290,863Apr 05, 2024, 04:14 PM
HIBBS KATHY LChief Administrative OfficerApr 04, 2024 Sale$0.5038,54819,2821,252,315Apr 05, 2024, 04:14 PM
HIBBS KATHY LChief Administrative OfficerMar 21, 2024 Option Exercise$0.4238,54816,1901,290,863Mar 22, 2024, 07:22 PM
HIBBS KATHY LChief Administrative OfficerMar 21, 2024 Sale$0.4638,54817,8941,252,315Mar 22, 2024, 07:22 PM
HIBBS KATHY LChief Administrative OfficerMar 07, 2024 Option Exercise$0.4238,54816,1901,290,863Mar 11, 2024, 04:09 PM
HIBBS KATHY LChief Administrative OfficerMar 07, 2024 Sale$0.5338,54820,4301,252,315Mar 11, 2024, 04:09 PM
HIBBS KATHY LChief Administrative OfficerFeb 22, 2024 Option Exercise$0.4238,54816,1901,278,375Feb 23, 2024, 05:09 PM
HIBBS KATHY LChief Administrative OfficerFeb 22, 2024 Sale$0.6138,54823,3251,239,827Feb 23, 2024, 05:09 PM
Richards William GHead of Therapeutics DiscoveryFeb 20, 2024 Option Exercise$0.7218,49713,244646,540Feb 21, 2024, 04:36 PM
Selsavage Joseph AnthonyInterim CFOFeb 20, 2024 Option Exercise$0.7242,39530,3551,273,659Feb 21, 2024, 04:35 PM
HIBBS KATHY LChief Administrative OfficerFeb 20, 2024 Option Exercise$0.7240,52229,0141,239,827Feb 21, 2024, 04:33 PM
HIBBS KATHY LChief Administrative OfficerFeb 15, 2024 Option Exercise$0.4238,54816,1901,318,897Feb 16, 2024, 04:47 PM
HIBBS KATHY LChief Administrative OfficerFeb 15, 2024 Sale$0.7838,54830,2101,280,349Feb 16, 2024, 04:47 PM
HIBBS KATHY LChief Administrative OfficerJan 25, 2024 Option Exercise$0.4238,54816,1901,318,897Jan 26, 2024, 08:24 PM
HIBBS KATHY LChief Administrative OfficerJan 25, 2024 Sale$0.7338,54827,9971,280,349Jan 26, 2024, 08:24 PM
HIBBS KATHY LChief Administrative OfficerJan 11, 2024 Option Exercise$0.4238,54816,1901,318,897Jan 12, 2024, 06:51 PM
HIBBS KATHY LChief Administrative OfficerJan 11, 2024 Sale$0.7238,54827,5811,280,349Jan 12, 2024, 06:51 PM
HIBBS KATHY LChief Administrative OfficerDec 28, 2023 Option Exercise$0.4238,54816,1901,318,897Dec 29, 2023, 04:04 PM
HIBBS KATHY LChief Administrative OfficerDec 28, 2023 Sale$0.9338,54835,9041,280,349Dec 29, 2023, 04:04 PM
HIBBS KATHY LChief Administrative OfficerDec 14, 2023 Option Exercise$0.4238,54816,1901,318,897Dec 18, 2023, 04:17 PM
HIBBS KATHY LChief Administrative OfficerDec 14, 2023 Sale$0.9738,54837,2221,280,349Dec 18, 2023, 04:17 PM
HIBBS KATHY LChief Administrative OfficerNov 30, 2023 Option Exercise$0.4238,54816,1901,318,897Dec 01, 2023, 04:22 PM
HIBBS KATHY LChief Administrative OfficerNov 30, 2023 Sale$0.8838,54833,7531,280,349Dec 01, 2023, 04:22 PM
HIBBS KATHY LChief Administrative OfficerNov 20, 2023 Option Exercise$0.914,6274,2111,280,349Nov 21, 2023, 04:45 PM
Richards William GHead of Therapeutics DiscoveryNov 20, 2023 Option Exercise$0.915,6955,182665,037Nov 21, 2023, 04:41 PM
Selsavage Joseph AnthonyInterim CFONov 20, 2023 Option Exercise$0.916,2085,6491,316,054Nov 21, 2023, 04:40 PM
HIBBS KATHY LChief Administrative OfficerNov 16, 2023 Option Exercise$0.4238,54816,1901,323,524Nov 17, 2023, 04:25 PM
HIBBS KATHY LChief Administrative OfficerNov 16, 2023 Sale$0.7738,54829,7321,284,976Nov 17, 2023, 04:25 PM
HIBBS KATHY LChief Administrative OfficerNov 02, 2023 Option Exercise$0.4238,54816,1901,323,524Nov 03, 2023, 07:02 PM
HIBBS KATHY LChief Administrative OfficerNov 02, 2023 Sale$0.8738,54833,4371,284,976Nov 03, 2023, 07:02 PM
HIBBS KATHY LChief Administrative OfficerOct 19, 2023 Option Exercise$0.4238,54816,1901,323,524Oct 20, 2023, 05:28 PM
HIBBS KATHY LChief Administrative OfficerOct 19, 2023 Sale$0.8138,54831,3971,284,976Oct 20, 2023, 05:28 PM
HIBBS KATHY LChief Administrative OfficerOct 05, 2023 Option Exercise$0.4238,54816,1901,323,524Oct 06, 2023, 05:16 PM
HIBBS KATHY LChief Administrative OfficerOct 05, 2023 Sale$0.8438,54832,4071,284,976Oct 06, 2023, 05:16 PM
HIBBS KATHY LChief Administrative OfficerSep 21, 2023 Option Exercise$0.4238,54816,1901,323,524Sep 25, 2023, 04:00 PM
HIBBS KATHY LChief Administrative OfficerSep 21, 2023 Sale$1.0038,54838,5831,284,976Sep 25, 2023, 04:00 PM
HIBBS KATHY LChief Administrative OfficerSep 07, 2023 Option Exercise$0.4240,89417,175299,880Sep 11, 2023, 04:04 PM
HIBBS KATHY LChief Administrative OfficerSep 07, 2023 Sale$1.0640,89443,483258,984Sep 11, 2023, 04:04 PM
Hernandez Sandra R MDDirectorSep 06, 2023 Option Exercise$1.0945,87149,999337,549Sep 08, 2023, 04:57 PM
MONTGOMERY RICE VALERIE MDDirectorSep 06, 2023 Option Exercise$1.0959,63365,000339,544Sep 08, 2023, 04:56 PM
Chung Patrick SDirectorSep 06, 2023 Option Exercise$1.0961,92667,499301,421Sep 08, 2023, 04:54 PM
BOTHA ROELOFDirectorSep 06, 2023 Option Exercise$1.0955,04559,999193,379Sep 08, 2023, 04:53 PM
Richards William GHead of Therapeutics DiscoverySep 05, 2023 Sale$1.082,5382,741211,041Sep 06, 2023, 05:01 PM
HIBBS KATHY LChief Administrative OfficerAug 24, 2023 Option Exercise$0.4240,89417,175293,406Aug 25, 2023, 04:57 PM
HIBBS KATHY LChief Administrative OfficerAug 24, 2023 Sale$1.0540,89443,119252,512Aug 25, 2023, 04:57 PM
HIBBS KATHY LChief Administrative OfficerAug 20, 2023 Option Exercise$1.144,6285,276252,512Aug 22, 2023, 04:25 PM
Selsavage Joseph AnthonyInterim CFOAug 20, 2023 Option Exercise$1.146,2097,078286,537Aug 22, 2023, 04:24 PM
Richards William GHead of Therapeutics DiscoveryAug 20, 2023 Option Exercise$1.148,1859,331211,041Aug 22, 2023, 04:22 PM
HIBBS KATHY LChief Administrative OfficerAug 15, 2023 Option Exercise$0.4240,89417,175298,034Aug 16, 2023, 04:51 PM
HIBBS KATHY LChief Administrative OfficerAug 15, 2023 Sale$1.3240,89453,939257,140Aug 16, 2023, 04:51 PM
HIBBS KATHY LChief Administrative OfficerJul 27, 2023 Option Exercise$0.4240,89417,175298,034Jul 31, 2023, 04:23 PM
HIBBS KATHY LChief Administrative OfficerJul 27, 2023 Sale$1.8940,89477,257257,140Jul 31, 2023, 04:23 PM
HIBBS KATHY LChief Administrative OfficerJul 13, 2023 Option Exercise$0.4240,89417,175298,034Jul 14, 2023, 04:33 PM
HIBBS KATHY LChief Administrative OfficerJul 13, 2023 Sale$1.8240,89474,239257,140Jul 14, 2023, 04:33 PM
HIBBS KATHY LChief Administrative OfficerJun 29, 2023 Option Exercise$0.4240,89417,175298,034Jun 30, 2023, 04:22 PM
HIBBS KATHY LChief Administrative OfficerJun 29, 2023 Sale$1.7240,89470,432257,140Jun 30, 2023, 04:22 PM
HIBBS KATHY LChief Administrative OfficerJun 05, 2023 Option Exercise$2.0815,09831,404257,140Jun 07, 2023, 04:22 PM
Hillan Kenneth J.Chief Therapeutics OfficerJun 05, 2023 Option Exercise$2.0815,34731,922221,876Jun 07, 2023, 04:20 PM
Selsavage Joseph AnthonyInterim CFOJun 05, 2023 Option Exercise$2.0813,07527,196292,746Jun 07, 2023, 04:18 PM
Selsavage Joseph AnthonyInterim CFOMay 20, 2023 Option Exercise$1.946,20912,045268,013May 23, 2023, 04:06 PM
Hillan Kenneth J.Chief Therapeutics OfficerMay 20, 2023 Option Exercise$1.944,6288,978192,842May 23, 2023, 04:05 PM
HIBBS KATHY LChief Administrative OfficerMay 20, 2023 Option Exercise$1.944,6288,978228,579May 23, 2023, 04:04 PM
Hillan Kenneth J.Chief Therapeutics OfficerFeb 20, 2023 Option Exercise$2.875,45715,662191,705Feb 22, 2023, 05:12 PM
Selsavage Joseph AnthonyInterim CFOFeb 20, 2023 Option Exercise$2.877,32121,011269,957Feb 22, 2023, 05:11 PM
HIBBS KATHY LChief Administrative OfficerFeb 20, 2023 Option Exercise$2.875,45715,662230,372Feb 22, 2023, 05:10 PM
HIBBS KATHY LChief Administrative OfficerDec 05, 2022 Sale$3.2526,25985,342235,829Dec 06, 2022, 05:44 PM
Selsavage Joseph AnthonyInterim CFONov 20, 2022 Option Exercise$2.9910,10530,214277,278Nov 22, 2022, 04:14 PM
HIBBS KATHY LChief Administrative OfficerNov 20, 2022 Option Exercise$2.994,62813,838262,088Nov 22, 2022, 04:12 PM
Hillan Kenneth J.Chief Therapeutics OfficerNov 20, 2022 Option Exercise$2.994,62813,838197,162Nov 22, 2022, 04:11 PM
SCHELLER RICHARD HDirectorNov 11, 2022 Sale$3.2418,42159,68472,388Nov 14, 2022, 04:38 PM
BOTHA ROELOFDirectorSep 06, 2022 Option Exercise$3.083,25110,013110,561Sep 08, 2022, 04:46 PM
Chung Patrick SDirectorSep 06, 2022 Option Exercise$3.083,41410,515113,034Sep 08, 2022, 04:45 PM
Hernandez Sandra R MDDirectorSep 06, 2022 Option Exercise$3.083,25110,013143,186Sep 08, 2022, 04:42 PM
MONTGOMERY RICE VALERIE MDDirectorSep 06, 2022 Option Exercise$3.083,57711,017149,049Sep 08, 2022, 04:41 PM
Hernandez Sandra R MDDirectorAug 25, 2022 Option Exercise$3.0313,20139,999125,302Aug 29, 2022, 04:33 PM
MONTGOMERY RICE VALERIE MDDirectorAug 25, 2022 Option Exercise$3.0317,82153,998130,839Aug 29, 2022, 04:32 PM
Chung Patrick SDirectorAug 25, 2022 Option Exercise$3.0318,81156,99794,987Aug 29, 2022, 04:31 PM
BOTHA ROELOFDirectorAug 25, 2022 Option Exercise$3.0316,50149,99892,677Aug 29, 2022, 04:30 PM
Hillan Kenneth J.Chief Therapeutics OfficerAug 24, 2022 Sale$3.648,75331,861196,083Aug 25, 2022, 05:00 PM
Schoch Steven JChief Financial OfficerAug 20, 2022 Option Exercise$3.334,78215,924211,663Aug 22, 2022, 06:12 PM
Hillan Kenneth J.Chief Therapeutics OfficerAug 20, 2022 Option Exercise$3.334,62815,411204,836Aug 22, 2022, 06:12 PM
HIBBS KATHY LChief Administrative OfficerAug 20, 2022 Option Exercise$3.334,62815,411263,636Aug 22, 2022, 06:11 PM
Schoch Steven JChief Financial OfficerJun 01, 2022 Option Exercise$2.824,78213,485216,445Jun 02, 2022, 04:28 PM
Hillan Kenneth J.Chief Therapeutics OfficerJun 01, 2022 Option Exercise$2.824,62713,048209,464Jun 02, 2022, 04:26 PM
HIBBS KATHY LChief Administrative OfficerJun 01, 2022 Option Exercise$2.824,62713,048268,264Jun 02, 2022, 04:25 PM
Lovell EvanDirectorMar 10, 2022 Buy$4.4111,46750,55811,467Mar 11, 2022, 04:05 PM
HIBBS KATHY LChief Legal OfficerJan 06, 2022 Option Exercise$0.4258,80024,69658,800Jan 07, 2022, 04:11 PM
Lemon StevenVice President, EngineeringJan 05, 2022 Option Exercise$0.23127,64729,359127,647Jan 07, 2022, 04:08 PM
BROWN DOUGLAS RDirectorOct 06, 2020 Buy$10.00100,0001,000,000100,000Oct 08, 2020, 08:22 PM
Load More Insider Transactions
Buy Sale Option Exercise
OwnerRelationshipDateValue($)
HIBBS KATHY LChief Administrative Officer04/04/202416,190
HIBBS KATHY LChief Administrative Officer04/04/202419,282
HIBBS KATHY LChief Administrative Officer03/21/202416,190
HIBBS KATHY LChief Administrative Officer03/21/202417,894
HIBBS KATHY LChief Administrative Officer03/07/202416,190
HIBBS KATHY LChief Administrative Officer03/07/202420,430
HIBBS KATHY LChief Administrative Officer02/22/202416,190
HIBBS KATHY LChief Administrative Officer02/22/202423,325
Richards William GHead of Therapeutics Discovery02/20/202413,244
Selsavage Joseph AnthonyInterim CFO02/20/202430,355
HIBBS KATHY LChief Administrative Officer02/20/202429,014
HIBBS KATHY LChief Administrative Officer02/15/202416,190
HIBBS KATHY LChief Administrative Officer02/15/202430,210
HIBBS KATHY LChief Administrative Officer01/25/202416,190
HIBBS KATHY LChief Administrative Officer01/25/202427,997
HIBBS KATHY LChief Administrative Officer01/11/202416,190
HIBBS KATHY LChief Administrative Officer01/11/202427,581
HIBBS KATHY LChief Administrative Officer12/28/202316,190
HIBBS KATHY LChief Administrative Officer12/28/202335,904
HIBBS KATHY LChief Administrative Officer12/14/202316,190
HIBBS KATHY LChief Administrative Officer12/14/202337,222
HIBBS KATHY LChief Administrative Officer11/30/202316,190
HIBBS KATHY LChief Administrative Officer11/30/202333,753
HIBBS KATHY LChief Administrative Officer11/20/20234,211
Richards William GHead of Therapeutics Discovery11/20/20235,182
Selsavage Joseph AnthonyInterim CFO11/20/20235,649
HIBBS KATHY LChief Administrative Officer11/16/202316,190
HIBBS KATHY LChief Administrative Officer11/16/202329,732
HIBBS KATHY LChief Administrative Officer11/02/202316,190
HIBBS KATHY LChief Administrative Officer11/02/202333,437
HIBBS KATHY LChief Administrative Officer10/19/202316,190
HIBBS KATHY LChief Administrative Officer10/19/202331,397
HIBBS KATHY LChief Administrative Officer10/05/202316,190
HIBBS KATHY LChief Administrative Officer10/05/202332,407
HIBBS KATHY LChief Administrative Officer09/21/202316,190
HIBBS KATHY LChief Administrative Officer09/21/202338,583
HIBBS KATHY LChief Administrative Officer09/07/202317,175
HIBBS KATHY LChief Administrative Officer09/07/202343,483
Hernandez Sandra R MDDirector09/06/202349,999
MONTGOMERY RICE VALERIE MDDirector09/06/202365,000
Chung Patrick SDirector09/06/202367,499
BOTHA ROELOFDirector09/06/202359,999
Richards William GHead of Therapeutics Discovery09/05/20232,741
HIBBS KATHY LChief Administrative Officer08/24/202317,175
HIBBS KATHY LChief Administrative Officer08/24/202343,119
HIBBS KATHY LChief Administrative Officer08/20/20235,276
Selsavage Joseph AnthonyInterim CFO08/20/20237,078
Richards William GHead of Therapeutics Discovery08/20/20239,331
HIBBS KATHY LChief Administrative Officer08/15/202317,175
HIBBS KATHY LChief Administrative Officer08/15/202353,939
HIBBS KATHY LChief Administrative Officer07/27/202317,175
HIBBS KATHY LChief Administrative Officer07/27/202377,257
HIBBS KATHY LChief Administrative Officer07/13/202317,175
HIBBS KATHY LChief Administrative Officer07/13/202374,239
HIBBS KATHY LChief Administrative Officer06/29/202317,175
HIBBS KATHY LChief Administrative Officer06/29/202370,432
HIBBS KATHY LChief Administrative Officer06/05/202331,404
Hillan Kenneth J.Chief Therapeutics Officer06/05/202331,922
Selsavage Joseph AnthonyInterim CFO06/05/202327,196
Selsavage Joseph AnthonyInterim CFO05/20/202312,045
Hillan Kenneth J.Chief Therapeutics Officer05/20/20238,978
HIBBS KATHY LChief Administrative Officer05/20/20238,978
Hillan Kenneth J.Chief Therapeutics Officer02/20/202315,662
Selsavage Joseph AnthonyInterim CFO02/20/202321,011
HIBBS KATHY LChief Administrative Officer02/20/202315,662
HIBBS KATHY LChief Administrative Officer12/05/202285,342
Selsavage Joseph AnthonyInterim CFO11/20/202230,214
HIBBS KATHY LChief Administrative Officer11/20/202213,838
Hillan Kenneth J.Chief Therapeutics Officer11/20/202213,838
SCHELLER RICHARD HDirector11/11/202259,684
BOTHA ROELOFDirector09/06/202210,013
Chung Patrick SDirector09/06/202210,515
Hernandez Sandra R MDDirector09/06/202210,013
MONTGOMERY RICE VALERIE MDDirector09/06/202211,017
Hernandez Sandra R MDDirector08/25/202239,999
MONTGOMERY RICE VALERIE MDDirector08/25/202253,998
Chung Patrick SDirector08/25/202256,997
BOTHA ROELOFDirector08/25/202249,998
Hillan Kenneth J.Chief Therapeutics Officer08/24/202231,861
Schoch Steven JChief Financial Officer08/20/202215,924
Hillan Kenneth J.Chief Therapeutics Officer08/20/202215,411
HIBBS KATHY LChief Administrative Officer08/20/202215,411
Schoch Steven JChief Financial Officer06/01/202213,485
Hillan Kenneth J.Chief Therapeutics Officer06/01/202213,048
HIBBS KATHY LChief Administrative Officer06/01/202213,048
Lovell EvanDirector03/10/202250,558
HIBBS KATHY LChief Legal Officer01/06/202224,696
Lemon StevenVice President, Engineering01/05/202229,359
BROWN DOUGLAS RDirector10/06/20201,000,000
Load More Insider Transactions
FUNDS WITH A POSITION IN 23ANDME HOLDING CO
Fund# Shares Owned% of Portfolio% ChangeInvesting Style
BLACKROCK INC.22,467,7610.00052%14.66%Other
GEODE CAPITAL MANAGEMENT, LLC7,058,6500.00067%15.3%Other
RENAISSANCE TECHNOLOGIES LLC3,478,0610.00492%23.46%Other
DRAGONEER INVESTMENT GROUP, LLC500,0000.00992%No changeGrowth
AQR CAPITAL MANAGEMENT LLC15,3670.00003%-10.34%Other
CHANGE IN SHARES OUTSTANDING FOR 23ANDME HOLDING CO
STOCK BUYBACKS FOR 23ANDME HOLDING CO
Period of Report
Previous Period
% Change in Shares
10-K/10-Q Filings
Quarter
12/31/2023
09/30/2023
1.25%
View
1Q
12/31/2023
06/30/2023
4.01%
View
2Q
12/31/2023
03/31/2023
5.40%
View
3Q
12/31/2023
12/31/2022
6.04%
View
4Q
12/31/2023
09/30/2022
6.87%
View
5Q
12/31/2023
06/30/2022
7.68%
View
6Q
12/31/2023
03/31/2022
32.99%
View
7Q
12/31/2023
12/31/2021
12.71%
View
8Q
12/31/2023
09/30/2021
18.17%
View
9Q
Load More

Period of Report: 12/31/2023

10-K/10-Q Filings: View

Previous Period
% Change in Shares
Quarter
09/30/2023
1.25%
1Q
06/30/2023
4.01%
2Q
03/31/2023
5.40%
3Q
12/31/2022
6.04%
4Q
09/30/2022
6.87%
5Q
06/30/2022
7.68%
6Q
03/31/2022
32.99%
7Q
12/31/2021
12.71%
8Q
09/30/2021
18.17%
9Q
Load More
BUYBACK ANNOUNCEMENT(S) FOR 23ANDME HOLDING CO
Active Completed
LOADING...

Looking for more premium content?

We have created a comprehensive group of tools that allows you to estimate the intrinsic value of investments.

Subscribe